Skip to main content
Search

# BoltzProt-1

1 related articles

Subscribe to updates
  1. Boltz

    Boltz raises $110M Series A: six of the world's 20 largest pharma companies are signed, and paying-customer molecular token use is up 50-fold since June

    Boltz announced a $110 million Series A led by Bessemer Venture Partners, with all existing investors doubling down. The company says it has signed six of the world's 20 largest pharma companies, including Pfizer, GSK, Takeda and BMS, and that molecular token usage among paying customers has grown 50-fold since June. The funding is meant to deepen compute and data investment, meet partner demand and expand the team.

You’re all caught up